Journal
NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 18, Issue 8, Pages 886-U43Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2081
Keywords
-
Funding
- Cancer Research UK
- Wellcome Trust
- UK Medical Research Council
- MRC [G0900084, G0700232] Funding Source: UKRI
- Medical Research Council [G0700232, G0900084] Funding Source: researchfish
Ask authors/readers for more resources
Wnt morphogens control embryonic development and homeostasis in adult tissues. In vertebrates the N-terminal WIF domain (WIF-1(WD)) of Wnt inhibitory factor 1 (WIF-1) binds Wnt ligands. Our crystal structure of WIF-1(WD) reveals a previously unidentified binding site for phospholipid; two acyl chains extend deep into the domain, and the head group is exposed to the surface. Biophysical and cellular assays indicate that there is a WIF-1(WD) Wnt-binding surface proximal to the lipid head group but also implicate the five epidermal growth factor (EGF)-like domains (EGFs I-V) in Wnt binding. The six-domain WIF-1 crystal structure shows that EGFs I-V are wrapped back, interfacing with WIF-1(WD) at EGF III. EGFs II-V contain a heparan sulfate proteoglycan (HSPG)-binding site, consistent with conserved positively charged residues on EGF IV. This combination of HSPG-and Wnt-binding properties suggests a modular model for the localization of WIF-1 and for signal inhibition within morphogen gradients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available